Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Fetal Hemoglobin Measurement per Red Blood Cell Provides Biological and Clinical Protective Thresholds

Nicolas Hebert, Rakotoson Marie Georgine, PhD, Gwellaouen Bodivit, Etienne Audureau, MD PhD, Nadia Oubaya, Sadaf Pakdaman, Mehdi Sakka, Gaetana Di Liberto, PhD, Philippe Chadebech, PhD, Benoît Vingert, PhD, France Pirenne, MD PhD, Frédéric Galactéros, MD PhD, Marie Cambot, PhD, Pablo Bartolucci, MD PhD

Blood (2019) 134 (Supplement_1): 1008.

https://doi.org/10.1182/blood-2019-126727

Published: 2019

Journal Articles

Protective Effects of Carbon Monoxide Delivered By Corm-401 in Hyperhemolysis in Patients with Sickle Cell Disease

Nguyen-Peyre Kim-Anh, PhD, Bodivit Gwellaouen, Foresti Roberta, PhD, Kiger Laurent, PhD, Gaetana Di Liberto, PhD, Philippe Chadebech, PhD, Alicia Jouard, Sadaf Pakdaman, Seguin Marion, Marden Micheal, PhD, France Pirenne, MD PhD, Motterlini Roberto, PhD, Pablo Bartolucci, MD PhD

Blood (2018) 132 (Supplement 1): 2367.

https://doi.org/10.1182/blood-2018-99-112900

Published: 2018

Journal Articles

Probability of TCD-Normalization in the "Drepagreffe" Trial Comparing Transplantation to Chronic Transfusion in Sickle Cell Anemia Children with Abnormal-Transcranial Doppler Is Associated with Lower Ang-2 and BDNF Plasma Levels

Myriam Bernaudin, PhD, Yacine Khelif, Philippe Chadebech, PhD, Gwellaouen Bodivit, Alicia Jouard, Suzanne Verlhac, MD, Catherine Paillard, MDPhD, Isabelle Thuret, MD, Corinne Guitton, MD, Camille Runel, MD, Florence Missud, MD, Cécile Arnaud, MD, Annie Kamdem, MD, Corinne Pondarré, MD PhD, France Pirenne, MD PhD, Francoise Bernaudin, MD

Blood (2018) 132 (Supplement 1): 506.

https://doi.org/10.1182/blood-2018-99-118091

Published: 2018

Journal Articles

Incidence and Risk of Delayed Hemolytic Transfusion Reaction in Sickle Cell Disease Patients Based on a Prospective Study

France Pirenne, MD PhD, David Narbey, PharmD, Philippe Chadebech, PhD, Armand Mekontso-Dessap, MD PhD, Pablo Bartolucci, MD PhD, Claire Rieux, MD, Marc Michel, MD, Sadaf Pakdaman, Rachid Djoudi, MD, Frédéric Galacteros, Anoosha Habibi

Blood (2016) 128 (22): 95.

https://doi.org/10.1182/blood.V128.22.95.95

Published: 2016

Journal Articles

Delayed Hemolytic Transfusion Reaction in Sickle Cell Disease Patients: Evidence of An Emerging Syndrome with Suicidal Erythrocyte Death

France Noizat-Pirenne, MD, PhD, Philippe Chadebech, PhD, Anoosha Habibi, MD, Dora Bachir, MD, Ruben Nzouakou, MD, Frederic Galacteros, MD, PhD, Philippe Bierling, MD, PhD

Blood (2008) 112 (11): 3037.

https://doi.org/10.1182/blood.V112.11.3037.3037

Published: 2008

Journal Articles

Successful Administration of Rituximab To Prevent Recurrence of Delayed Haemolytic Transfusion Reaction Developed in a Sickle Cell Disease Patient.

France Noizat-Pirenne, MD, PhD, Philippe Chadebech, PhD, Marc Michel, MD, Dora Bachir, MD, Frederic Galacteros, MD, PhD, Philippe Bierling, MD, PhD

Blood (2007) 110 (11): 2904.

https://doi.org/10.1182/blood.V110.11.2904.2904

Published: 2007

Journal Articles

A Severe Case of Delayed Haemolytic Transfusion Reaction in a Sickle Cell Disease Patient: Immuno-Haematological Study, Cytokine Transcripts and Lymphocyte Subsets Analysis.

France Noizat-Pirenne, MD, PhD, Helene Ansart-Pirenne, MD, PhD, Anne Plonquet, MD, PhD, Philippe Chadebech, PhD, Anoosha Habibi, MD, Dora Bachir, MD, Frederic Galacteros, MD, PhD, Philippe Bierling, MD, PhD

Blood (2005) 106 (11): 954.

https://doi.org/10.1182/blood.V106.11.954.954

Published: 2005

NARROW

Fetal Hemoglobin Measurement per Red Blood Cell Provides Biological and Clinical Protective Thresholds

Protective Effects of Carbon Monoxide Delivered By Corm-401 in Hyperhemolysis in Patients with Sickle Cell Disease

Probability of TCD-Normalization in the "Drepagreffe" Trial Comparing Transplantation to Chronic Transfusion in Sickle Cell Anemia Children with Abnormal-Transcranial Doppler Is Associated with Lower Ang-2 and BDNF Plasma Levels

Incidence and Risk of Delayed Hemolytic Transfusion Reaction in Sickle Cell Disease Patients Based on a Prospective Study

Delayed Hemolytic Transfusion Reaction in Sickle Cell Disease Patients: Evidence of An Emerging Syndrome with Suicidal Erythrocyte Death

Successful Administration of Rituximab To Prevent Recurrence of Delayed Haemolytic Transfusion Reaction Developed in a Sickle Cell Disease Patient.

A Severe Case of Delayed Haemolytic Transfusion Reaction in a Sickle Cell Disease Patient: Immuno-Haematological Study, Cytokine Transcripts and Lymphocyte Subsets Analysis.

Email alerts

ASH Publications

American Society of Hematology

Fetal Hemoglobin Measurement per Red Blood Cell Provides Biological and Clinical Protective Thresholds

Protective Effects of Carbon Monoxide Delivered By Corm-401 in Hyperhemolysis in Patients with Sickle Cell Disease

Probability of TCD-Normalization in the "Drepagreffe" Trial Comparing Transplantation to Chronic Transfusion in Sickle Cell Anemia Children with Abnormal-Transcranial Doppler Is Associated with Lower Ang-2 and BDNF Plasma Levels

Incidence and Risk of Delayed Hemolytic Transfusion Reaction in Sickle Cell Disease Patients Based on a Prospective Study

Delayed Hemolytic Transfusion Reaction in Sickle Cell Disease Patients: Evidence of An Emerging Syndrome with Suicidal Erythrocyte Death

Successful Administration of Rituximab To Prevent Recurrence of Delayed Haemolytic Transfusion Reaction Developed in a Sickle Cell Disease Patient.

A Severe Case of Delayed Haemolytic Transfusion Reaction in a Sickle Cell Disease Patient: Immuno-Haematological Study, Cytokine Transcripts and Lymphocyte Subsets Analysis.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only